Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 4Dermatologic 4Sarcoma 1

Conditions

Colorectal Neoplasms 2Turcot syndrome 1Pancreatic Neoplasms 1Advanced Pancreatic Cancer 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 324Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × IMM-101 × Gastrointestinal × Clear all
NCT06498518 2025-07-11

PRIMUS006

University of Glasgow

Phase 2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT05118724 2025-06-15

ANTONIO

AIO-Studien-gGmbH

Phase 2 Active not recruiting
80 enrolled
Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

NCT01539824 2024-11-25

A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer

Immodulon Therapeutics Ltd

Phase 2 Completed
12 enrolled 6 charts
Gastrointestinal

Colorectal Neoplasms

NCT01303172 2021-11-10

A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer

Immodulon Therapeutics Ltd

Phase 2 Completed
110 enrolled 14 charts
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡